Age-Related Macular Degeneration and Circadian Preference. [PDF]
Garces E+5 more
europepmc +1 more source
Harnessing nanofibers for targeted delivery of phytoconstituents in age-related macular degeneration. [PDF]
Andrades U+4 more
europepmc +1 more source
Antioxidants in Age-Related Macular Degeneration: Lights and Shadows. [PDF]
Parmar UPS+9 more
europepmc +1 more source
The quality, accuracy and appropriateness of UK optometric age-related macular degeneration referrals. [PDF]
Fulcher C, Davey C, Denniss J.
europepmc +1 more source
Utilization of Nanoparticles for Treating Age-Related Macular Degeneration. [PDF]
Nikolaidou A+6 more
europepmc +1 more source
Diagnostic testing in the genetically complex age-related macular degeneration. [PDF]
Kiel C, Weber BHF.
europepmc +1 more source
Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration. [PDF]
Wada I+11 more
europepmc +1 more source
Therapeutic effect of dihydroartemisinin on Alzheimer's disease model mice with senile macular degeneration. [PDF]
Han G+6 more
europepmc +1 more source
Possible Association Between Dopamine Antagonists and Increased Conversion to Exudative Age-Related Macular Degeneration. [PDF]
Weng PJ, Morgan R, Grewal DS, Fekrat S.
europepmc +1 more source
The role of peripheral blood microRNAs in the pathogenesis and treatment response of age-related macular degeneration. [PDF]
Kong M, Li J, Tong N.
europepmc +1 more source